Shuimu Biosciences
Explicitly offers small-molecule MicroED and presents protein and peptide MicroED examples, separately from SPA services.
Corporate information
- Company entity
- 水木未来 / Shuimu Biosciences
- Headquarters / principal office
- Beijing, China (headquarters); Cambridge, Massachusetts, USA (US office)Corporate website explicitly identifies headquarters; location follows the retrieved disclosure. ↗
- Founded
- 2017 ↗
- Official corporate reference
- https://www.shuimu.us/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Secondary reporting confirms a capital event. Some databases label it Series C, but a consistent primary-source designation was not obtained; no label is imposed.
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
The MicroED workflow includes crystal screening, continuous-rotation cryo-EM data collection, processing, structure solution, and CIF reporting.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.